Skip to main content

  • Outcomes of Coronary Artery Revascularization Procedures in Patients with Antiphospholipid Syndrome

    • Posted: 12/23/2019
    • Author:

      Navid Ahmed, Himali Gandhi, Eliany Mejia Lopez, Neeraja Yedlapati, Daniel Spevack

    • CRM2019

    Highlights

    • There are high rates of arterial thrombosis in Antiphospholipid syndrome (APS).
    • This raises concern for increased repeat revascularization.
    • Repeat revascularization occurred in only a third of our sample.
    • Coronary artery revascularization in APS is not prohibitively high.

    Abstract

    Background

    Published data on the outcome of coronary artery revascularization in patients with antiphospholipid syndrome (APS) are limited. Because APS is associated with a high rate of arterial thrombosis, there is concern that coronary revascularization in this group may be complicated by increased need for repeat revascularization. We aimed to determine the incidence and timing of repeat revascularization performed in patients with APS undergoing percutaneous coronary interventions (PCI) or coronary artery bypass grafting (CABG).

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details